X0508 4 2025-08-21-05:00 false 0000924515 GUIDED THERAPEUTICS INC GTHP 0001348439 Imhoff John E 5853 PEACHTREE CORNERS EAST SUITE B PEACHTREE CORNERS GA 30092 true false true false false Common Stock 2025-08-21-05:00 4 J false 104448 A 18096828 D Preferred Series E Stock 2025-08-21-05:00 4 J false 300 D 100 D Common Stock 2025-08-21-05:00 4 J false 1200000 A 19296828 D Common Stock 2025-08-29-05:00 4 P false 166667 0.18 A 19463495 D Warrants 0.25 2025-08-29-05:00 4 P false 166667 A 2025-08-29-05:00 2029-08-29-05:00 Common Stock 166667 191667 D These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298. On August 21, 2025, Mr. Imhoff converted 300 shares of Series E preferred stock into 1,200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price. On August 29, 2025, the Company entered into a Securities Purchase Agreement with Dr. Imhoff, pursuant to which the Company agreed to sell, for a total price of $30,000, 166,667 units, each unit consisting of one share of common stock and one warrant to purchase up to 166,667 shares of common stock (the "August Warrants"). The August Warrants were immediately exercisable upon issuance, expire four years following the issuance date and have an exercise price of $0.25 per share. /s/ John E. Imhoff 2025-09-04-05:00